Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies
- PMID: 17434906
- DOI: 10.1373/clinchem.2006.079632
Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies
Abstract
Background: For the laboratory diagnosis of the antiphospholipid syndrome (APS) we developed a biosensor with the ability to distinguish between disease-relevant anti-beta2-glycoprotein I (beta2GPI) autoantibodies (anti-beta2GPI) and pathogen-specific beta2GPI cross-reactive antibodies that occur transiently during infections.
Methods: We used a surface plasmon resonance (SPR) biosensor device. For the detection of anti-beta2GPI in serum samples, affinity-purified human beta2GPI was covalently attached to a functionalized n-alkanethiol self-assembling monolayer on the biosensor chip. After verifying the specificity of the biosensor system with a panel of monoclonal antibodies to beta2GPI, we analyzed sera from healthy donors and patients suffering from APS, systemic lupus erythematosus (SLE), syphilis, or parvovirus B19 infections. The SPR results were compared with beta2GPI-specific ELISA.
Results: Using the SPR biosensor, we recorded antigen binding curves with response levels in the range of 50-500, resonance units (RU) for anti-beta2GPI ELISA-positive APS patient sera. The amplitudes of the antiphospholipid antibody (APL) responses in the biosensor correlated with the overall IgG and IgM anti-beta2GPI ELISA titers with a correlation coefficient of 0.87. Moreover, we observed immunoglobulin isotype-specific association and dissociation profiles for APL binding of different APS patient sera to the biosensor-immobilized beta2GPI. In contrast to APS patient samples, no significant anti-beta2GPI binding (response levels <35 RU) was observed in samples from healthy individuals or from patients suffering from SLE, syphilis, or parvovirus B19 infection.
Conclusions: The SPR biosensor system enables specific detection of APS-associated beta2GPI-reactive APL and differentiation from beta2GPI cross-reactive antibodies that occur frequently during acute infections. The established association/dissociation plot for anti-beta2GPI responses in APS patient sera gives additional information regarding the influence of anti-beta2GPI IgG and IgM isotype distribution.
Similar articles
-
Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus.Arthritis Rheum. 1997 Jan;40(1):103-8. doi: 10.1002/art.1780400115. Arthritis Rheum. 1997. PMID: 9008606
-
Antiphospholipid syndrome: 30 years and our contribution.Int J Rheum Dis. 2015 Feb;18(2):233-41. doi: 10.1111/1756-185X.12438. Epub 2014 Dec 19. Int J Rheum Dis. 2015. PMID: 25524556 Review.
-
Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.Arthritis Rheum. 2002 Aug;47(4):414-20. doi: 10.1002/art.10510. Arthritis Rheum. 2002. PMID: 12209489
-
Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.Clin Rheumatol. 2019 Feb;38(2):371-378. doi: 10.1007/s10067-018-4251-7. Epub 2018 Aug 11. Clin Rheumatol. 2019. PMID: 30099654
-
β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease.Front Immunol. 2018 Dec 10;9:2836. doi: 10.3389/fimmu.2018.02836. eCollection 2018. Front Immunol. 2018. PMID: 30619248 Free PMC article. Review.
Cited by
-
Surface plasmon resonance applications in clinical analysis.Anal Bioanal Chem. 2014 Apr;406(9-10):2303-23. doi: 10.1007/s00216-014-7647-5. Epub 2014 Feb 25. Anal Bioanal Chem. 2014. PMID: 24566759 Free PMC article. Review.
-
Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.Immunol Res. 2015 Feb;61(1-2):35-44. doi: 10.1007/s12026-014-8578-0. Immunol Res. 2015. PMID: 25395339
-
Clinical application of surface plasmon resonance-based biosensors for fetal fibronectin detection.Sensors (Basel). 2012;12(4):3879-90. doi: 10.3390/s120403879. Epub 2012 Mar 26. Sensors (Basel). 2012. PMID: 22666007 Free PMC article.
-
Evaluation of the sensitivity and specificity of a novel line immunoassay for the detection of criteria and non-criteria antiphospholipid antibodies in comparison to established ELISAs.PLoS One. 2019 Jul 24;14(7):e0220033. doi: 10.1371/journal.pone.0220033. eCollection 2019. PLoS One. 2019. PMID: 31339913 Free PMC article.
-
Biosensors in clinical chemistry - 2011 update.Clin Chim Acta. 2011 Sep 18;412(19-20):1749-61. doi: 10.1016/j.cca.2011.06.025. Epub 2011 Jun 26. Clin Chim Acta. 2011. PMID: 21729694 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous